安諾其(300067.SZ):1559萬元競得北溝鎮一宗工業用地
格隆匯 2 月 4日丨安諾其(300067.SZ)公佈,2020年2月9日,公司召開總經理辦公會議,會議決議投資建設“年產10,000噸廣譜消毒劑單過硫酸氫鉀複合鹽項目”,投資金額為8000萬元人民幣。
近日,公司已競拍取得該項目土地使用權,公司全資子公司煙台安諾其精細化工有限公司與煙台市蓬萊區自然資源和規劃局簽訂了《國有建設用地使用權出讓合同》;宗地編號:370684002003GB00501;宗地總面積:61119平方米;宗地位置:北溝鎮G228國道南、海潤路西;宗地用途:工業用地;出讓年期:50年;出讓價款:1559萬元。
此次簽訂《國有建設用地使用權出讓合同》,將有利於公司推進“年產10,000噸廣譜消毒劑單過硫酸氫鉀複合鹽項目”的建設,延伸公司消毒劑產業鏈,進一步提升產品競爭優勢,增加經濟效益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.